Total Payments
$6,123
2024 Payments
$1,022
Companies
38
Transactions
474
Medicare Patients
7,104
Medicare Billing
$324,825
Payment Breakdown by Category
Food & Beverage$6,104 (99.7%)
Other$18.80 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,104 | 473 | 99.7% |
| Debt forgiveness | $18.80 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,514 | 134 | $0 (2024) |
| Lilly USA, LLC | $764.25 | 72 | $0 (2024) |
| PFIZER INC. | $460.38 | 39 | $0 (2024) |
| Novo Nordisk Inc | $424.29 | 42 | $0 (2024) |
| Merck Sharp & Dohme LLC | $284.08 | 19 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $212.63 | 13 | $0 (2024) |
| Amgen Inc. | $196.03 | 11 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $179.62 | 12 | $0 (2022) |
| Phathom Pharmaceuticals, Inc. | $153.22 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $146.36 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,022 | 82 | ABBVIE INC. ($244.35) |
| 2023 | $1,494 | 108 | ABBVIE INC. ($494.26) |
| 2022 | $1,658 | 140 | ABBVIE INC. ($342.99) |
| 2021 | $1,949 | 144 | AbbVie Inc. ($432.07) |
All Payment Transactions
474 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/01/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/22/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Neuroscience | ||||||
| 10/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.34 | General |
| Category: NEUROLOGY | ||||||
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: PAIN | ||||||
| 09/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.72 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.70 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $4.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.28 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,724 | 2,701 | $196,236 | $88,139 |
| 2022 | 38 | 2,160 | 3,711 | $227,639 | $92,846 |
| 2021 | 32 | 1,962 | 3,822 | $207,023 | $83,586 |
| 2020 | 24 | 1,258 | 2,481 | $162,449 | $60,254 |
Total Patients
7,104
Total Services
12,715
Medicare Billing
$324,825
Procedure Codes
122
All Medicare Procedures & Services
122 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 355 | 692 | $69,200 | $35,375 | 51.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 87 | 87 | $20,532 | $9,286 | 45.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 93 | 115 | $17,710 | $8,682 | 49.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 26 | 26 | $8,450 | $7,053 | 83.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 36 | 36 | $9,640 | $6,559 | 68.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 38 | 38 | $3,040 | $2,661 | 87.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 67 | $5,025 | $2,258 | 44.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 163 | 228 | $2,280 | $1,915 | 84.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 134 | 156 | $13,260 | $1,615 | 12.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $3,124 | $1,502 | 48.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 143 | 174 | $5,220 | $1,324 | 25.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 87 | 96 | $4,992 | $1,260 | 25.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 39 | 39 | $1,170 | $1,117 | 95.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 18 | 19 | $1,900 | $993.08 | 52.3% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 19 | 36 | $3,780 | $965.01 | 25.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 26 | 26 | $780.00 | $735.00 | 94.2% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 32 | 34 | $2,550 | $709.36 | 27.8% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 35 | 35 | $2,800 | $643.28 | 23.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 57 | 75 | $3,000 | $585.90 | 19.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 48 | 61 | $2,318 | $580.72 | 25.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 19 | 19 | $2,280 | $578.47 | 25.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 30 | 32 | $2,016 | $526.72 | 26.1% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 43 | 53 | $3,445 | $439.37 | 12.8% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 68 | 86 | $1,720 | $267.46 | 15.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 48 | 324 | $3,240 | $228.73 | 7.1% |
About Craig Mueller, FNP
Craig Mueller, FNP is a Nurse Practitioner healthcare provider based in Wake Village, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164448155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Craig Mueller, FNP has received a total of $6,123 in payments from pharmaceutical and medical device companies, with $1,022 received in 2024. These payments were reported across 474 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($6,104).
As a Medicare-enrolled provider, Mueller has provided services to 7,104 Medicare beneficiaries, totaling 12,715 services with total Medicare billing of $324,825. Data is available for 4 years (2020–2023), covering 122 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Wake Village, TX
- Active Since 07/14/2006
- Last Updated 02/04/2013
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1164448155
Products in Payments
- VRAYLAR (Drug) $758.84
- ELIQUIS (Drug) $411.54
- UBRELVY (Drug) $379.77
- QULIPTA (Drug) $375.06
- Ozempic (Drug) $245.86
- EMGALITY (Drug) $235.54
- BELSOMRA (Drug) $226.52
- TRULICITY (Drug) $207.47
- MOUNJARO (Drug) $186.66
- VOQUEZNA (Drug) $153.22
- FARXIGA (Drug) $150.24
- TRINTELLIX (Drug) $148.11
- Vascepa (Drug) $135.16
- JARDIANCE (Drug) $133.44
- TRELEGY ELLIPTA (Drug) $131.40
- XARELTO (Drug) $125.86
- ENTRESTO (Drug) $117.39
- Aimovig (Biological) $105.89
- Rybelsus (Drug) $103.64
- Livalo (Drug) $97.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.